Metagenics Recalls Spectrazyme Due to Potential Chloramphenicol Contamination
Metagenics is recalling Spectrazyme supplements because raw materials may contain the antibiotic chloramphenicol. The recall covers products distributed in the US and several international markets.
- Product
- Spectrazyme, 180 count, 60 count, 12 bottles/case, 20000 tablets/box, 14000 capsules/pail.
- Category
- Food
- Distribution
- Distributed nationwide